The Ministry of Health prepared a number of practical positive changes for people, Members gave them the green light in the National Council on Tuesday 9 June. The ban on the sale of personal protective equipment will be partially released, and FFP 2 respirators can be sold to the general public. They are safer than normal drapes, and MZ recommends using them during the COVID-19 pandemic to people who come into contact with people with respiratory disease or to people who have arrived from countries that the government does not currently consider safe countries. To limit their sales only to health professionals, VÚC and force forces, the government approached the Central Crisis Staff recommendation because of their acute market shortage. As a result of this measure, their price fell. We approached the current release of sales due to their availability on the market, said Minister of Health of the SR Marek Krajčí.In view of the current situation of the COVID-19 pandemic and the associated reduced capacity of medical devices, MEPs have approved an extension of the period during which the ratio of the health insurance company to the premium for the drug can be changed so that the farm firm can reduce the premium for the patient's medicine to a financially viable level.If we had not prepared a legislative change in the ministry, which MEPs approved today, on 1 July some patients would have obtained an unbearable increase in their medicines, more than EUR 50 per pack. Their prescribed treatment would thus make them financially unavailable, Chief of Health Department explained Marek Krajčí. The patient comes first for the resort phrase. The Ministry of Health makes all changes in the first place with regard to the patient. In the adverse epidemiological situation related to the COVID-19 pandemic, some groups of patients could not or could not be switched to another treatment for an additional supplement. At the same time, in the proposed legislative measure, we also found reference groups for unmistakable medicines. In those cases, patients couldn't even get to cheaper treatment. Thanks to its measure, the Ministry has quantified the potential savings in patients' wallets to more than 10 million. the euro on which the farm firms are composed, explained Minister M. Krajčí with the fact that from 1.7. even pharmaceutical companies can reduce the surcharges for medicines for patients that are higher than 30 euros per box. Legislative change of

Workshops of the Ministry of Health were also supported by the Association for the Protection of Patients' Rights. If the law had not been passed, it would not have been possible to compensate for the surcharge for 50 reference groups since 1 July, of which only 34 reference groups contain the drug without surcharge and 16 have no possibility of the drug without surcharge. In total, 141 medicines, generic, biologically similar and original, would not be able to compensate for the patient's surcharge. Extra fees for the packaging of the product would range from 50 to 200 euros, saidPresident of the Patient Rights Association Mary Levy. The approved legislation also abolishes the temporary suspension of the further training of health professionals, which was necessary in relation to the protection of public health during the COVID-19 pandemic. At the same time, it allows the trainer to take account of the practice of those healthcare professionals who have not been interrupted due to epidemiological restrictions.